Therefore, clinicians are more likely to treat patients at higher risk of OHSS with a GnRH agonist trigger in the short IVF protocol rather than to use an hCG trigger in the long IVF protocol. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.